Morpholine → HCID 22250082, 화합물
반응식
[Cl:1][C:2]1[CH:7]=[CH:6][N:5]=[C:4]2[CH:8]=[C:9]([C:11]3[S:12][C:13]([C:17](Cl)=[O:18])=[C:14]([CH3:16])[N:15]=3)[S:10][C:3]=12.[NH:20]1[CH2:25][CH2:24][O:23][CH2:22][CH2:21]1>>[Cl:1][C:2]1[CH:7]=[CH:6][N:5]=[C:4]2[CH:8]=[C:9]([C:11]3[S:12][C:13]([C:17]([N:20]4[CH2:25][CH2:24][O:23][CH2:22][CH2:21]4)=[O:18])=[C:14]([CH3:16])[N:15]=3)[S:10][C:3]=12참가 물질
3
실험 절차
[2-(7-Chloro-thieno[3,2-b]pyridin-2-yl) -4-methyl-thiazol-5-yl]-morpholin-4-yl-methanone (532 mg, 82%) was prepared from 2-(7-Chloro-thieno[3,2-b]pyridin-2-yl)-4-methyl-thiazole-5-carbonyl chloride and morpholine in a procedure analogous to Example 20. C16H14ClN3O2S2: APCI m/z 380.0/382.1 (pos.).
출처 및 근거
- ORD 기록
- ord-b5ed3b757c7c402096e4e906d89e19a7
- 출처 데이터셋
- uspto-grants-2006_02
- 특허 번호
- US06995171B2
반응 노트
불러오는 중…